RESUMO
BACKGROUND: Although there is strong evidence that plasma HDL levels correlate inversely with the incidence of coronary artery disease, the precise mechanism(s) for the protective effect of HDLs remains unclear. We recently showed that HDLs inhibit endothelial cell expression of cytokine-induced leukocyte adhesion molecules in vitro. Our study therefore sought to test the hypothesis that elevating the level of circulating HDLs would inhibit endothelial cell activation in vivo. METHODS AND RESULTS: We used a porcine model of inflammation previously established in our laboratory, in which the level of vascular endothelial cell expression of E-selectin in interleukin (IL)-1alpha-induced skin lesions was measured by the uptake of a radiolabeled anti-E-selectin antibody (1.2B6). Porcine plasma HDL levels were elevated by use of a bolus injection of reconstituted discoidal HDL (recHDL). These particles resemble nascent HDL particles in shape and contain apolipoprotein A-I as the sole protein and soybean phosphatidylcholine as the sole phospholipid. We found that recHDLs inhibited the expression of IL-1alpha-induced E-selectin by porcine aortic endothelial cells in vitro, confirming that the inhibitory effect is conserved with synthetic HDLs and demonstrating that the phenomenon is not restricted to human endothelial cells. In vivo, elevating the circulating level of HDLs approximately 2-fold led to significant inhibition of basal and IL-1alpha-induced E-selectin expression by porcine microvascular endothelial cells. CONCLUSIONS: These observations demonstrate the potential anti-inflammatory action of HDLs and provide support for the further investigation of the mechanisms underlying the inhibitory effects of HDLs on endothelial cell activation.
Assuntos
Selectina E/biossíntese , Endotélio Vascular/metabolismo , Inflamação/metabolismo , Interleucina-1/metabolismo , Lipoproteínas HDL/sangue , Doença Aguda , Animais , Anticorpos Monoclonais/metabolismo , Aorta , Apolipoproteína A-I/sangue , Apolipoproteína A-I/farmacologia , Células Cultivadas , Modelos Animais de Doenças , Portadores de Fármacos , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/patologia , Citometria de Fluxo , Inflamação/patologia , Interleucina-1/farmacologia , Lipoproteínas HDL/farmacocinética , Lipoproteínas HDL/farmacologia , Especificidade de Órgãos , Proteínas Recombinantes/sangue , Proteínas Recombinantes/farmacocinética , Proteínas Recombinantes/farmacologia , Pele/irrigação sanguínea , Pele/patologia , SuínosRESUMO
To investigate the metabolism of nascent HDLs, apoA1/phosphatidylcholine (apoA1/PC) discs were infused IV over 4 hours into 7 healthy men. Plasma total apoA1 and phospholipid (PL) concentrations increased during the infusions. The rise in plasma apoA1 was greatest in small prebeta-migrating particles not present in the infusate. Total HDL unesterified cholesterol (UC) also increased simultaneously. After stopping the infusion, the concentrations of apoA1, PL, HDL UC, and small prebeta HDLs decreased, whereas those of HDL cholesteryl ester (CE) and large alpha-migrating apoA1 containing HDLs increased. ApoB-containing lipoproteins became enriched in CEs. Addition of apoA1/PC discs to whole blood at 37 degrees C in vitro also generated small prebeta HDLs, but did not augment the transfer of UC from erythrocytes to plasma. We conclude that the disc infusions increased the intravascular production of small prebeta HDLs in vivo, and that this was associated with an increase in the efflux and esterification of UC derived from fixed tissues. The extent to which the increase in tissue cholesterol efflux was dependent on that in prebeta HDL production could not be determined. Infusion of discs also reduced the plasma apoB and apoA2 concentrations, and increased plasma triglycerides and apoC3. Thus, nascent HDL secretion may have a significant impact on prebeta HDL production, reverse cholesterol transport and lipoprotein metabolism in humans.
Assuntos
Apolipoproteína A-I/administração & dosagem , Lipoproteínas/sangue , Fosfatidilcolinas/administração & dosagem , Adulto , Apolipoproteína A-I/efeitos adversos , Apolipoproteína A-I/sangue , Apolipoproteína A-II/sangue , Apolipoproteínas B/sangue , Apolipoproteínas C/sangue , Colatos/sangue , Cromatografia em Gel , Combinação de Medicamentos , Humanos , Imunoeletroforese Bidimensional , Infusões Intravenosas , Masculino , Fosfatidilcolinas/efeitos adversos , Fosfolipídeos/sangueRESUMO
Properties of a new anti-D immunoglobulin were assessed in Rh(D) negative healthy male adults. Six volunteers received intravenous, and five volunteers intramuscular injections of 200 micrograms anti-D, 48 hours after pre-treatment with 5 mL of Rh(D) positive erythrocytes. Immediately after intravenous administration of anti-D, a rapid decrease of the Rh(D) positive erythroyctes was noted. After intramuscular injection of anti-D, there was a lag phase of 6 hours until the erythrocytes decreased, and the elimination rate was slower. Twenty-four hours after injection of anti-D, the Rh(D) positive erythrocytes were at the detection limit or no longer detectable in all volunteers. After intravenous administration, anti-D serum levels decreased from 45 ng/mL at 2 hours to 29 ng/mL at 24 hours, whereas after intramuscular administration, anti-D became detectable at 4 hours and increased to 11 ng/mL at 24 hours. During subsequent months, anti-D serum levels decreased at similar rates in both groups. After six months, anti-D was not detectable in any of the volunteers. Thus, the new anti-D immunoglobulin induced elimination of the Rh(D) positive erythrocytes and suggested that Rh(D) immunization of the volunteers was prevented.
Assuntos
Eritrócitos/imunologia , Isoimunização Rh , Imunoglobulina rho(D)/sangue , Adulto , Humanos , Cinética , Masculino , Taxa de Depuração Metabólica , Valores de Referência , Viroses/transmissãoRESUMO
A reconstituted high density lipoprotein (rHDL) prepared for clinical use was tested for its influence on platelet activity modulated by various stimuli. In a first series of in vitro experiments, rHDL was added to blood in a concentration series, and platelet rich plasma (PRP) was isolated. Platelets were stimulated with arachidonic acid, collagen, epinephrine or ADP, and platelet aggregation was assessed. rHDL mediated a dose dependent inhibition of the platelet activity. With purified platelets rHDL inhibited the release reaction induced by collagen, but not by thrombin, as measured by CD62P (P-Selectin) expression on the plasma membrane. Ex vivo experiments were performed with PRP from volunteers, previously infused with 25 mg rHDL/kg body weight and 40 mg rHDL/kg body weight, respectively. Platelet activity in PRP was assessed before, and up to 30 h after the end of the rHDL infusion. A transient inhibition of the platelet aggregation induced by arachidonic acid and collagen was observed which was more pronounced in the group receiving 40 mg rHDL/kg body weight. In both groups of experiments, in vitro and ex vivo, the inhibition of the platelet activity was also dependent on the stimulus used.
Assuntos
Lipoproteínas HDL/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Humanos , Infusões Intravenosas , Lipídeos/sangue , Masculino , Valores de ReferênciaRESUMO
A chromatographic fractionation method has been developed for the production of a liquid-stable anti-D immunoglobulin product for intravenous and intramuscular use. An immunoglobulin fraction, highly enriched with anti-D immunoglobulins, was isolated by cation-exchange column chromatography and further polished, first by anion-exchange chromatography, followed by an aluminium hydroxide gel treatment. The process includes two specific steps for virus inactivation and removal, namely S/D treatment and nanofiltration. The overall anti-D process yield is about 56%. The final product is stabilised with human albumin and glycine and placed in ready-to-use syringes. The anti-D product was shown to be stable in liquid state for at least 30 months at 4 degrees C.
Assuntos
Imunoglobulina rho(D)/isolamento & purificação , Fracionamento Químico , Cromatografia por Troca Iônica , Contaminação de Medicamentos , Estabilidade de Medicamentos , Feminino , Testes de Hemaglutinação , Humanos , Masculino , Reprodutibilidade dos Testes , Isoimunização Rh/prevenção & controle , Imunoglobulina rho(D)/efeitos adversos , Imunoglobulina rho(D)/sangue , Imunoglobulina rho(D)/farmacologia , Vírus/isolamento & purificaçãoRESUMO
High-density lipoproteins (HDL) can bind and neutralize lipopolysaccharides (LPS) in vitro and in vivo. HDL can also affect fibrinolytic activity and can directly influence platelet function by reducing platelet aggregation. In this study, the effects of reconstituted HDL (rHDL) on LPS-induced coagulation, fibrinolysis and platelet activation in humans were investigated. In a double-blind, randomized, placebo-controlled, cross-over study, eight healthy male volunteers were injected with LPS (4 ng/kg) on two occasions, once in conjunction with rHDL (40 mg/kg, given as a 4 h infusion starting 3.5 h prior to LPS injection), and once in conjunction with placebo. rHDL significantly reduced LPS-induced activation of coagulation (plasma levels of prothrombin fragment F1 + 2) and fibrinolysis (plasma levels of tissue type plasminogen activator antigen, t-PA). No effect was observed on LPS-induced inhibition of the fibrinolytic pathway (PAI-1) or on the transient thrombocytopenia elicited by LPS. Furthermore, rHDL treatment significantly enhanced the inhibition of collagen-stimulated inhibition of platelet aggregation during endotoxemia, but had no such effect on arachidonate-stimulated platelet aggregation. rHDL treatment per se also reduced collagen-induced platelet aggregation. These results indicate that rHDL modifies the procoagulant state associated with endotoxemia.
Assuntos
Coagulação Sanguínea/efeitos dos fármacos , Endotoxemia/tratamento farmacológico , Fibrinólise/efeitos dos fármacos , Lipopolissacarídeos/antagonistas & inibidores , Lipoproteínas HDL/farmacologia , Ativação Plaquetária/efeitos dos fármacos , Adulto , Estudos Cross-Over , Citocinas/sangue , Método Duplo-Cego , Endotoxemia/sangue , Endotoxinas/efeitos adversos , Endotoxinas/antagonistas & inibidores , Humanos , Lipoproteínas HDL/uso terapêutico , Masculino , Fragmentos de Peptídeos/análise , Inibidor 1 de Ativador de Plasminogênio/análise , Agregação Plaquetária , Protrombina/análiseRESUMO
High-density lipoprotein (HDL) has been found to neutralize LPS activity in vitro and in animals in vivo. We sought to determine the effects of reconstituted HDL (rHDL) on LPS responsiveness in humans in a double-blind, randomized, placebo-controlled, cross-over study. rHDL, given as a 4-h infusion at 40 mg/kg starting 3.5 h before endotoxin challenge (4 ng/kg), reduced flu-like symptoms during endotoxemia, but did not influence the febrile response. rHDL potently reduced the endotoxin-induced release of TNF, IL-6, and IL-8, while only modestly attenuating the secretion of proinflammatory cytokine inhibitors IL-1ra, soluble TNF receptors and IL-10. In addition, rHDL attenuated LPS-induced changes in leukocyte counts and the enhanced expression of CD11b/CD18 on granulocytes. Importantly, rHDL infusion per se, before LPS administration, was associated with a downregulation of CD14, the main LPS receptor, on monocytes. This effect was biologically relevant, since monocytes isolated from rHDL-treated whole blood showed reduced expression of CD14 and diminished TNF production upon stimulation with LPS. These results suggest that rHDL may inhibit LPS effects in humans in vivo not only by binding and neutralizing LPS but also by reducing CD14 expression on monocytes.
Assuntos
Apolipoproteína A-I/metabolismo , Apolipoproteína A-I/uso terapêutico , Colesterol/metabolismo , Colesterol/uso terapêutico , Endotoxemia/tratamento farmacológico , Endotoxinas/metabolismo , Inflamação/tratamento farmacológico , Lipopolissacarídeos/metabolismo , Lipoproteínas HDL/metabolismo , Lipoproteínas HDL/uso terapêutico , Fosfatidilcolinas/metabolismo , Fosfatidilcolinas/uso terapêutico , Adulto , Antígenos CD , Estudos Cross-Over , Método Duplo-Cego , Granulócitos , Humanos , Infusões Intravenosas , Interleucina-6/sangue , Interleucina-8/sangue , Contagem de Leucócitos , Masculino , Monócitos , Náusea , Dor , Placebos , Estremecimento , Fatores de Tempo , Fator de Necrose Tumoral alfa/análise , VômitoRESUMO
A method is described for the large scale preparation of reconstituted high density lipoproteins (rHDL) suitable for therapeutic use. Apolipoprotein A-I (apoA-I was isolated from precipitates obtained by cold ethanol fractionation of human plasma. This process includes several steps for virus removal and virus inactivation, among them pasteurization. Reconstitution of lipoprotein particles was performed by cholate dialysis using soybean phosphatidylcholine as the lipid source. An apoA-I:lipid ratio of 1:150 (mol:mol) was obtained. Redissolved rHDLs were disc-shaped particles resembling nascent HDL, as assessed by electron microscopy. The method was optimized for low content of free apoA-I protein as well as the low concentration of free lipid. The product was stabilized by lyophilization in the presence of sucrose. In vitro studies show potential effects it the prevention of gram-negative septic shock and in the inhibition of atherosclerosis.
Assuntos
Lipoproteínas HDL/química , Apolipoproteína A-I/isolamento & purificação , Cromatografia em Gel , Ativação Enzimática , Humanos , Lipopolissacarídeos/metabolismo , Peso Molecular , Fosfatidilcolina-Esterol O-Aciltransferase/metabolismo , FosfatidilcolinasRESUMO
A reconstituted lipoprotein, containing human apolipoprotein A-I and phosphatidylcholine (1:200, molar ratio), referred to as ApoLipo, was used prophylactically in an endotoxin shock model in anesthetized rabbits. ApoLipo was administered at a dose of 75 mg protein/kg body weight 15 min before the beginning of a slow, continuous lipopolysaccharide (LPS, endotoxin) infusion (4.17 micrograms LPS/kg/hr). During the 6 hr LPS infusion, the Control-LPS group manifested a marked increase in serum tumor necrosis factor (TNF, peak value 7.82 [2.7-11.2] ng/ml at 1 hr), and many of the pathophysiologic sequelae of endotoxin shock, including hypotension (MAP: 59 +/- 7 mmHg) and metabolic acidosis (BE: -9.9 +/- 2.7) at 3 hr, and a severe neutropenia developed rapidly (PMN count: 5 +/- 3% of baseline at 30 min). In the ApoLipo treated group, serum TNF levels did not rise during the course of LPS infusion (0.1 [0.06-0.64] ng/ml at 1 hr). Hypotension (77 +/- 2 mmHg) and acidosis (-2.7 +/- 0.4) were also significantly attenuated, and the appearance of leukopenia was delayed by 1 hr (110 +/- 12% at 30 min, but 9 +/- 2% at 2 hr). Endotoxemia in the ApoLipo treated group was reduced in comparison to controls, albeit nonsignificantly. The infusion of the same dose of phosphatidylcholine without apoA-I was significantly less efficacious.
Assuntos
Apolipoproteína A-I/farmacologia , Choque Séptico/tratamento farmacológico , Fator de Necrose Tumoral alfa/metabolismo , Acidose/prevenção & controle , Animais , Modelos Animais de Doenças , Endotoxinas , Hipotensão/prevenção & controle , Leucopenia/prevenção & controle , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Fosfatidilcolinas , Contagem de Plaquetas , CoelhosRESUMO
To further define the role of fibrin(ogen) and fibronectin in Staphylococcus aureus adherence to central venous catheters, the amount, chemical integrity, and biologic activity of these proteins adsorbed on lines inserted in hospitalized patients were prospectively studied. Polyurethane cannulas promoted a significantly lower adherence of S. aureus than polyvinyl chloride (P < .01) or Hickman (P < .001) cannulas and contained the lowest amount of immunologically assayed fibronectin but not of fibrin(ogen). Fibrinogen showed an extensive loss of adherence-promoting activity on inserted cannulas, which was related to its proteolytic breakdown, as detected by SDS-PAGE and immunoblots with antifibrinogen antibodies and confirmed by in vitro studies with purified protein fragments. In contrast, either intact or fragmented fibronectin, although present in much lower amounts than fibrin(ogen), could actively promote S. aureus adherence onto intravenous catheters.
Assuntos
Aderência Bacteriana/fisiologia , Fibrina/fisiologia , Fibrinogênio/fisiologia , Fibronectinas/fisiologia , Staphylococcus aureus/fisiologia , Anticoagulantes , Cateterismo Venoso Central , Cateteres de Demora , Eletroforese em Gel de Poliacrilamida , Fibrina/metabolismo , Produtos de Degradação da Fibrina e do Fibrinogênio/fisiologia , Fibrinogênio/metabolismo , Fibrinolisina/fisiologia , Fibronectinas/metabolismo , Humanos , Hidrólise , Imunoglobulina G/biossíntese , Técnicas In Vitro , Poliuretanos , Cloreto de Polivinila , Estudos Prospectivos , Fatores de TempoRESUMO
To determine whether immunoglobulins of the IgG class diffus up to the corneal center after subconjunctival injection, rabbits were injected with fluorescein-isothiocyanate-labeled human IgG. The inoculum diffused from the entire periphery centrepetally towards the corneal center. The progression of the diffusion front slowed down as the distance to the limbus increased. The first increase of fluorescence in the corneal center was observed on day 6. The intensity increased during the following 10 days despite resorption in the corneal periphery due to the flow of IgG from paracentral toward central areas. The diffusion coefficient of 0.003-0.004 cm2/day was calculated by computer simulation using Fickian diffusion equations adapted for corneal geometry. We conclude that after subconjunctival application, IgG diffuses up to the corneal center with a delay of several days and that the penetration speed decreases as the distance to the limbus increases. This kinetics contributes to our understanding of the role of IgG in corneal pathology and may help to design therapeutic schedules for immunotherapy with IgG.
Assuntos
Simulação por Computador , Túnica Conjuntiva/metabolismo , Substância Própria/metabolismo , Imunoglobulina G/metabolismo , Animais , Transporte Biológico , Difusão , Tolerância a Medicamentos , Fluoresceína-5-Isotiocianato/metabolismo , Injeções , Cinética , CoelhosRESUMO
Apolipoproteins A-I and A-II were isolated from precipitates obtained by cold ethanol fractionation of human plasma. The starting material used in this report was precipitate B of the Kistler and Nitschmann method which corresponds approximately to fraction III of the Cohn and Oncley procedure. Through the use of urea, chloroform, and ethanol in appropriate concentrations, apolipoproteins A-I and A-II were isolated by a simple extraction technique avoiding time-consuming ultracentrifugation. Starting from 10 g of centrifuged precipitate B, approximately 100 mg of apolipoprotein A-I and 10 mg of apolipoprotein A-II were obtained. When incubated with normal human or rabbit plasma, both apolipoproteins were readily incorporated into high-density lipoproteins. Apolipoprotein A-I obtained by the cold ethanol method activated lecithin-cholesterol acyltransferase to the same extent as apolipoprotein A-I prepared by the classical flotation method. Apolipoprotein A-II had no such properties by itself, but was capable of potentiating lecithin-cholesterol acyltransferase activity of apolipoprotein A-I.
Assuntos
Apolipoproteínas A/isolamento & purificação , Fosfatidilcolina-Esterol O-Aciltransferase/sangue , Apolipoproteína A-I , Apolipoproteína A-II , Western Blotting , Eletroforese em Gel de Poliacrilamida , Humanos , UltracentrifugaçãoRESUMO
Recent data suggest that fibronectin may favor Staphylococcus aureus infection by promoting attachment to either injured tissues or implanted foreign bodies. Using a previously described in vitro assay, we show that promotion of S. aureus adherence by surface-bound fibronectin, adsorbed on polymethylmethacrylate (PMMA) coverslips, is antagonized by antistaphylococcal antibodies present in immunoglobulin G (IgG) purified from human plasma. Among the different organisms tested, the protein A-deficient strain Wood 46 of S. aureus was the most strongly inhibited by purified IgG or whole serum dose-dependently. Bacterial adherence was not influenced by preincubating fibronectin-coated PMMA with either purified IgG or whole serum. However, inhibition of bacterial adherence was directly related to the extent of IgG binding to S. aureus Wood 46. When F(ab')2 fragments of purified IgG were tested in the adherence assay, they could also reduce the interaction between S. aureus Wood 46 and fibronectin-coated PMMA. Two other staphylococcal strains were also tested in the adherence inhibition assay: Whereas the protein A-rich strain Cowan I of S. aureus was moderately inhibited by purified IgG or whole serum, S. epidermidis KH 11 was not at all inhibited by IgG which bound poorly to the bacterial cells. This study has demonstrated that bacterial coating by humoral factors, and specifically IgG, may influence significantly subsequent adherence of S. aureus to surface-bound fibronectin.
Assuntos
Aderência Bacteriana , Fibronectinas/metabolismo , Imunoglobulina G/farmacologia , Ácidos Polimetacrílicos , Staphylococcus aureus/fisiologia , Fragmentos Fab das Imunoglobulinas/farmacologia , Especificidade da Espécie , Staphylococcus epidermidis/fisiologiaRESUMO
Specific binding of purified histidine rich glycoprotein (HRGP) to human platelets stimulated with either bisdiazoniumbenzidine-crosslinked immunoglobulin G (BDB-IgG), with thrombin or with collagen was dose- and divalent cation dependent. A 5-10-fold increase of platelet bound 125I-HRGP was obtained when 0.5-0.8 x 10(9) platelets/ml were activated with 100 micrograms BDB-IgG/ml, 0.1 U thrombin/ml or 15 micrograms collagen/ml. At maximal binding tested 16,000 molecules of HRGP became bound per platelet, but saturation was not achieved. Such platelet inhibitors as acetylsalicylic acid, prostaglandin E1 and cytochalasin B reduced the capacity of platelets to bind ligand, and by kinetic experiments involving enzymatic digestion of radiolabelled bound HRGP the ligand revealed to remain surface bound rather than being taken up to inner parts of the cell.
Assuntos
Plaquetas/metabolismo , Proteínas Sanguíneas , Glicoproteínas/sangue , Benzidinas , Cálcio/fisiologia , Humanos , Imunoglobulina G , Magnésio/fisiologia , Proteínas/antagonistas & inibidoresRESUMO
From a panel of IgG1 myeloma proteins, only one was found to interact with human monocyte FcR in a manner similar to that of polyclonal IgG. This protein was used in binding studies involving human macrophage Fc receptors. A monomeric fraction depleted of dimeric and polymeric IgG1 was crosslinked with bis-diazonium benzidine, and a fraction highly enriched in cross linked IgG1 dimers was radiolabeled. Labeled monomeric and dimeric IgG were allowed to interact with monocytes that had matured to macrophages in vitro. The association with macrophages at 4 degrees C, in the presence of cytochalasin B, reached a plateau after 6 hr. The dissociation induced by excess unlabeled IgG followed similar kinetics as the association, but 20-30% of the bound IgG could not be dissociated. Under equilibrium conditions, evidence for a single FcR population binding monomeric IgG was obtained, the Kd being in the range of 12-42 nM. In contrast, the binding of dimeric IgG was more consistent with a model assuming two populations of binding sites when appropriate curve-fitting calculations were applied. The high-affinity FcR population had a Kd in the range of 0.8-3.5 nM, whereas the Kd of the low-affinity FcR population was in the range of 28-85 nM. When macrophages had been pre-treated with recombinant interferon-gamma, the expression of high-affinity sites was increased by a factor of 1.5-3, but the number of low-affinity sites was not augmented. Cytofluorographic analyses confirmed the increased expression of high-affinity FcR, binding fluoresceinating murine IgG2a. The expression of CD16, a low-affinity FcR expressed on neutrophils, NK cells and macrophages, as well as the expression of the complement receptor type III was little influenced by the rIFN-gamma pretreatment.
Assuntos
Imunoglobulina G/imunologia , Macrófagos/imunologia , Receptores Fc/imunologia , Afinidade de Anticorpos , Antígenos de Diferenciação/imunologia , Sítios de Ligação de Anticorpos , Citometria de Fluxo , Humanos , Interferon gama/imunologia , Cinética , Ativação de Macrófagos , Monócitos/imunologia , Proteínas do Mieloma/metabolismo , Fagocitose , Receptores de IgGRESUMO
The effect of recombinant interferon-gamma (rIFN-gamma) on human macrophage functions was studied, using monocytes which had matured to macrophages within hydrophobic containers. Following exposure to rIFN-gamma, the number of surface-expressed specific IgG-binding sites was increased. This increase was restricted to high-affinity Fc receptors (FcR), however; low-affinity FcR were not increased in number. Exposure to rIFN-gamma led to an enhanced chemiluminescence (CL) signal in the presence of luminol and a variety of respiratory burst stimuli, such as zymosan, phorbol 12-myristate 13-acetate or IgG-sensitized sheep erythrocytes (EA). In contrast, phagocytosis of EA was markedly depressed in rIFN-gamma-treated cells. Both increase in CL response and decrease in phagocytic activity were manifest after 1 day of treatment and were more pronounced after 2 days. While 5 U/ml of rIFN-gamma was an insufficient dose, 50 to 5000 U/ml yielded significant dose-dependent changes in both functional assays. Thus, using rIFN-gamma as a biological response-modifier, FcR expression and FcR-mediated CL can be dissociated from FcR-mediated phagocytosis.
Assuntos
Interferon gama/farmacologia , Macrófagos/efeitos dos fármacos , Receptores Fc/metabolismo , Relação Dose-Resposta Imunológica , Humanos , Medições Luminescentes , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Monócitos/citologia , Consumo de Oxigênio , Fagocitose/efeitos dos fármacos , Proteínas Recombinantes/farmacologiaRESUMO
Fc receptor-mediated phagocytosis was measured with monocytes subjected to various treatments. Monocytes exposed to IgG during their adherence, or after they had adhered to a surface, experienced functional impairment. This was manifested in the requirement of a higher antibody density on target particle for efficient phagocytosis, and in an enhanced susceptibility to inhibition by fluid-phase IgG. The impairment was found to be due to an interaction of IgG adhering to the surface with the Fc receptors. This effect could be induced with monomeric IgG, devoid of IgG aggregates or immune complexes. IgG coatings that resulted in inefficient Clq fixation promoted considerable functional impairment of monocytes within 1 hr. In addition, the prolonged contact of monocytes with polystyrene in the absence of IgG also led to a functional reduction. The study points to a compromised function of phagocytes exposed to artificial surfaces.
Assuntos
Imunoglobulina G/imunologia , Monócitos/imunologia , Fagocitose , Receptores Fc/imunologia , Proteínas Sanguíneas/farmacologia , Adesão Celular , Humanos , Imunoglobulina G/análise , PoliestirenosRESUMO
The effect of purified human plasma fibronectin on stimulation of human platelets with crosslinked immunoglobulin G (IgG) was tested by means of aggregometry, 14C-serotonin release and fibronectin-to-platelet binding experiments. Incremental additions of fibronectin to gel-filtered platelets (8 X 10(8)/ml) followed by 25 micrograms/ml bisdiazoniumbenzidine (BDB)-crosslinked IgG produced a dose-related inhibition of platelet aggregation and suppression of 14C-serotonin release from the platelets. Evidence was obtained that upon stimulation of the platelets with BDB-IgG, fibronectin becomes bound to its receptor and that further platelet activation is inhibited when a sufficient number of receptors is occupied.
Assuntos
Fibronectinas/farmacologia , Imunoglobulina G/imunologia , Agregação Plaquetária/efeitos dos fármacos , Benzidinas/farmacologia , Relação Dose-Resposta a Droga , Humanos , Técnicas In Vitro , Receptores de Fibronectina , Receptores Imunológicos/metabolismo , Serotonina/sangue , Fatores de TempoRESUMO
The capacity of immunoglobulin for intravenous application (IgG-IV) to interact with Fc receptors of human monocytes and macrophages was tested by quantifying the inhibition of phagocytosis of IgG-sensitized erythrocytes. To this end a spectrometric phagocytosis test has been used. When compared with IgG for i.m. use (IgG-IM), all IgG-IV had reduced activity. This reduction was related, in part, to the reduced amount of IgG dimers and polymers in IgG-IV. On a weight basis dimeric IgG and polymeric IgG exerted 6-fold and 14-fold higher activity, respectively, than monomeric IgG. When this difference was corrected for, chemically modified IgG-IV still had significantly reduced inhibitory activity; DEAE-Sephadex-treated IgG and acid-treated IgG had an activity similar to IgG-IM, and PEG-treated IgG showed a slightly reduced activity. Pepsin-treated IgG was greater than 100-fold less active than IgG-IM. The reactivity of IgG-IV with monocyte and macrophage Fc receptors was closely correlated. The most conspicuous differences found were related to the concentration at which IgG was used. Thus, beta-propiolactone-treated IgG and plasmin-treated IgG were found to have significantly reduced activity at concentrations greater than 20 micrograms/ml, but almost normal activity when used at lower concentrations.
Assuntos
Imunização Passiva , Imunoglobulinas/imunologia , Macrófagos/imunologia , Monócitos/imunologia , Receptores Fc/imunologia , Células Cultivadas , Humanos , Imunoglobulinas/administração & dosagem , Injeções Intravenosas , FagocitoseRESUMO
Supernatant fluids were prepared from human platelets (2-2.5 X 10(10)/ml) after sonication of stimulation with cross-linked IgG; together with plasma samples from two patients with different types of pemphigus, they enhanced acantholysis in cultured punch biopsy specimens of human skin. In the absence of pemphigus plasma the platelet-derived materials did not induce acantholysis. The acantholysis-enhancing effect persisted after exhaustive dialysis or heating (56 degrees C, 30 min). The platelet-derived materials did not contain plasminogen activator; plasminogen itself was detectable by zymographic analysis, although in quantities too low (0.2-0.5 micrograms/ml) to account for the acantholysis-enhancing activity. We conclude that the platelet could contribute to the pathogenesis of pemphigus. The nature of the platelet-derived acantholysis-enhancing factors is presently unknown.